Shinil Clonixin Lysinate Tablets

Adult dose

○ Adults: Administer 125∼250 mg of clonixin lysinate orally 3 times daily.

This medication should be discussed with a doctor or pharmacist for individuals who regularly consume more than three glasses of alcohol a day. The risk of gastrointestinal bleeding may increase when taken with alcohol. This medication may affect the cardiovascular system, potentially leading to serious cardiovascular issues such as myocardial infarction or stroke. Individuals with cardiovascular diseases or risk factors should exercise caution and consult healthcare professionals if symptoms occur. It can also affect the gastrointestinal tract, causing serious issues such as bleeding, ulcers, or perforation in the stomach or intestines. Such side effects may suddenly present without symptoms, so elderly individuals and those with a history of gastrointestinal disease should be especially careful. Patients with a history of peptic ulcers, those with gastrointestinal bleeding, individuals allergic to the drug or its components, those with a history of asthma or allergic reactions, pregnant women or those who may become pregnant, individuals with severe liver or kidney disease, severe heart failure patients, and those with inflammatory bowel disease should not take this medication. Taking it in conjunction with other non-steroidal anti-inflammatory drugs, ACE inhibitors, angiotensin II receptor antagonists, aspirin, diuretics, lithium, methotrexate, anticoagulants, cyclosporine, tacrolimus, antiplatelet drugs, selective serotonin reuptake inhibitors, corticosteroids, etc., may increase the risk of side effects, so it should only be used after discussion with healthcare professionals. Individuals with a history of peptic ulcers, hypertension, heart failure, asthma, or any liver or kidney dysfunction should consult a doctor or pharmacist before taking this medication. During use, if symptoms such as gastrointestinal bleeding, skin rash, difficulty breathing, blood abnormalities, liver function abnormalities, severe headaches, or drowsiness occur, the medication should be stopped immediately and healthcare professionals should be consulted. The medication should be used for the shortest duration and at the lowest effective dose. Regular blood tests and monitoring of liver and kidney function are necessary with long-term use. Pregnant or breastfeeding women should avoid this medication, and breastfeeding should be discontinued or medication should be stopped if breastfeeding is continued. This medication should be kept out of reach of children and should not be transferred to other containers.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, bleeding from the stomach or intestines, ulcers, perforation, nausea, vomiting, diarrhea, constipation, abdominal pain, peptic ulcer, shock, rash, itching, anemia, elevated AST, elevated ALT, drowsiness, headache, dizziness, cold sweat, chills, unusual euphoria, jaundice, fulminant hepatitis, liver necrosis, liver failure, anemia, exfoliative dermatitis, mucocutaneous syndrome, toxic epidermal necrolysis, severe bronchospasm

Drug interactions

Do not take this medicine together with non-steroidal anti-inflammatory drugs, ACE inhibitors or angiotensin II receptor antagonists, aspirin, diuretics, lithium, methotrexate, anticoagulants of the coumarin type (such as warfarin), cyclosporine and tacrolimus, antiplatelet agents, selective serotonin reuptake inhibitors (SSRIs), or corticosteroids. If you are taking misoprostol as a treatment for peptic ulcers, consult your doctor or pharmacist.

This medication should be stored in a tightly closed container to prevent exposure to air or moisture and should be kept at room temperature between 1 degree and 30 degrees Celsius.

Appearance

White film-coated round tablets

Package unit

10 tablets (1 tablet/pack X10), 10 tablets (10 tablets/PTP)